Financhill
Sell
48

SYK Quote, Financials, Valuation and Earnings

Last price:
$364.26
Seasonality move :
9.11%
Day range:
$365.50 - $369.22
52-week range:
$329.16 - $406.19
Dividend yield:
0.92%
P/E ratio:
48.05x
P/S ratio:
5.80x
P/B ratio:
6.42x
Volume:
939.8K
Avg. volume:
1.7M
1-year change:
-6.4%
Market cap:
$139.9B
Revenue:
$22.6B
EPS (TTM):
$7.62

Analysts' Opinion

  • Consensus Rating
    Stryker Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 13 Buy ratings, 10 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $428.96, Stryker Corp. has an estimated upside of 17.22% from its current price of $365.95.
  • Price Target Downside
    According to analysts, the lowest downside price target is $316.00 representing 13.65% downside risk from its current price of $365.95.

Fair Value

  • According to the consensus of 23 analysts, Stryker Corp. has 17.22% upside to fair value with a price target of $428.96 per share.

SYK vs. S&P 500

  • Over the past 5 trading days, Stryker Corp. has underperformed the S&P 500 by -2.44% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Stryker Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Stryker Corp. has grown year-over-year revenues for 21 quarters straight. In the most recent quarter Stryker Corp. reported revenues of $6.1B.

Earnings Growth

  • Stryker Corp. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Stryker Corp. reported earnings per share of $2.22.
Enterprise value:
153.7B
EV / Invested capital:
3.95x
Price / LTM sales:
5.80x
EV / EBIT:
27.89x
EV / Revenue:
6.31x
PEG ratio (5yr expected):
1.10x
EV / Free cash flow:
37.75x
Price / Operating cash flow:
34.72x
Enterprise value / EBITDA:
23.11x
Gross Profit (TTM):
$15.1B
Return On Assets:
6.51%
Net Income Margin (TTM):
12.07%
Return On Equity:
14.06%
Return On Invested Capital:
7.89%
Operating Margin:
22.52%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $19.9B $22B $24.4B $5.5B $6.1B
Gross Profit $12B $13.5B $15.1B $3.4B $3.7B
Operating Income $4.1B $4.7B $5.5B $1.2B $1.4B
EBITDA $5.1B $5.8B $6.7B $1.4B $1.7B
Diluted EPS $6.74 $9.33 $7.62 $2.16 $2.22
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $9.5B $9.3B $11B $14.7B $13.7B
Total Assets $34.1B $36B $38B $43.8B $47.1B
Current Liabilities $4.4B $4.6B $7.5B $7.7B $7.4B
Total Liabilities $20B $19.5B $20.1B $23.7B $25.3B
Total Equity $14.2B $16.5B $17.9B $20.1B $21.8B
Total Debt $13.1B $13.1B $13.1B $15.9B $17B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $3.2B $3.8B $4.8B $1.5B $1.5B
Cash From Investing -$972M -$2.8B -$4.9B -$2.2B -$321M
Cash From Financing -$1.8B $983M -$588M $2.7B -$339M
Free Cash Flow $2.6B $3.2B $4.1B $1.3B $1.4B
SYK
Sector
Market Cap
$139.9B
$28.4M
Price % of 52-Week High
90.09%
50.35%
Dividend Yield
0.92%
0%
Shareholder Yield
0.29%
-1.32%
1-Year Price Total Return
-6.4%
-22.19%
Beta (5-Year)
0.890
0.521
Dividend yield:
0.92%
Annualized payout:
$3.24
Payout ratio:
37.81%
Growth streak:
15 years

Technicals

8-day SMA
Sell
Level $370.25
200-day SMA
Sell
Level $377.35
Bollinger Bands (100)
Sell
Level 365.64 - 389.82
Chaikin Money Flow
Buy
Level 1B
20-day SMA
Buy
Level $364.78
Relative Strength Index (RSI14)
Sell
Level 48.10
ADX Line
Buy
Level 15.25
Williams %R
Neutral
Level -55.6774
50-day SMA
Sell
Level $368.57
MACD (12, 26)
Buy
Level 0.16
25-day Aroon Oscillator
Buy
Level 52
On Balance Volume
Neutral
Level 1.1B

Financial Scores

Buy
Altman Z-Score (Annual)
Level (5.4087)
Buy
CA Score (Annual)
Level (0.1765)
Buy
Beneish M-Score (Annual)
Level (-2.5753)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-1.4636)
Buy
Piotroski F Score (Annual)
Level (8)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (10)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.

Stock Forecast FAQ

In the current month, SYK has received 13 Buy ratings 10 Hold ratings, and 0 Sell ratings. The SYK average analyst price target in the past 3 months is $428.96.

  • Where Will Stryker Corp. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Stryker Corp. share price will rise to $428.96 per share over the next 12 months.

  • What Do Analysts Say About Stryker Corp.?

    Analysts are divided on their view about Stryker Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Stryker Corp. is a Sell and believe this share price will drop from its current level to $316.00.

  • What Is Stryker Corp.'s Price Target?

    The price target for Stryker Corp. over the next 1-year time period is forecast to be $428.96 according to 23 Wall Street analysts, 13 of them rate the stock a Buy, 0 rate the stock a Sell, and 10 analysts rate the stock a Hold.

  • Is SYK A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Stryker Corp. is a Buy. 13 of 23 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of SYK?

    You can purchase shares of Stryker Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Stryker Corp. shares.

  • What Is The Stryker Corp. Share Price Today?

    Stryker Corp. was last trading at $364.26 per share. This represents the most recent stock quote for Stryker Corp.. Yesterday, Stryker Corp. closed at $365.95 per share.

  • How To Buy Stryker Corp. Stock Online?

    In order to purchase Stryker Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Buy
65
Is AAPL Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 38x

Buy
69
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
47
PSTG alert for Dec 4

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
41
SMX alert for Dec 4

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
43
HY alert for Dec 4

Hyster-Yale, Inc. [HY] is up 1.92% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock